UCB SA (UCBJF)
OTCMKTS
· Delayed Price · Currency is USD
189.57
+2.19 (1.17%)
At close: Feb 21, 2025
UCB SA Employees
As of December 31, 2023, UCB SA had 9,083 total employees, including 8,450 full-time and 633 part-time employees. The number of employees increased by 380 or 4.37% compared to the previous year.
Employees
9,083
Change (1Y)
380
Growth (1Y)
4.37%
Revenue / Employee
$649,309
Profits / Employee
$28,572
Market Cap
36.05B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
UCB SA News
- 4 weeks ago - United Community Banks, Inc. (UCB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - United Community Banks Non-GAAP EPS of $0.63 beats by $0.07, revenue of $239.47M misses by $3.26M - Seeking Alpha
- 5 weeks ago - UCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX® (bimekizumab-bkzx) - Benzinga
- 7 weeks ago - United Community Banks Inc (UCB) Announces Upcoming Fourth Quarter 2024 Financial Results Release - GuruFocus
- 2 months ago - United Community Banks to acquire ANB Holdings in an all-stock deal - Seeking Alpha
- 3 months ago - Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside - Benzinga
- 3 months ago - FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease - Benzinga
- 3 months ago - UCB gets FDA approval for Bimzelx for hidradenitis suppurativa - Seeking Alpha